Attention is all you need: utilizing attention in AI-enabled drug discovery

Author:

Zhang Yang1,Liu Caiqi23,Liu Mujiexin4,Liu Tianyuan5,Lin Hao6ORCID,Huang Cheng-Bing7,Ning Lin89

Affiliation:

1. Innovative Institute of Chinese Medicine and Pharmacy, Academy for Interdiscipline, Chengdu University of Traditional Chinese Medicine , Chengdu, China

2. Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, No.150 Haping Road, Nangang District , Harbin, Heilongjiang 150081, China

3. Key Laboratory of Molecular Oncology of Heilongjiang Province, No.150 Haping Road, Nangang District , Harbin, Heilongjiang 150081, China

4. Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology, Chengdu University of Traditional Chinese Medicine , Chengdu, China

5. Graduate School of Science and Technology, University of Tsukuba , Tsukuba, Japan

6. School of Life Science and Technology, University of Electronic Science and Technology of China , Chengdu 610054, China

7. School of Computer Science and Technology, Aba Teachers University , Aba, China

8. Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China , Quzhou, Zhejiang, China

9. School of Healthcare Technology, Chengdu Neusoft University , Chengdu 611844, China

Abstract

Abstract Recently, attention mechanism and derived models have gained significant traction in drug development due to their outstanding performance and interpretability in handling complex data structures. This review offers an in-depth exploration of the principles underlying attention-based models and their advantages in drug discovery. We further elaborate on their applications in various aspects of drug development, from molecular screening and target binding to property prediction and molecule generation. Finally, we discuss the current challenges faced in the application of attention mechanisms and Artificial Intelligence technologies, including data quality, model interpretability and computational resource constraints, along with future directions for research. Given the accelerating pace of technological advancement, we believe that attention-based models will have an increasingly prominent role in future drug discovery. We anticipate that these models will usher in revolutionary breakthroughs in the pharmaceutical domain, significantly accelerating the pace of drug development.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Sichuan Province

China Postdoctoral Science Foundation

Sichuan Province Postdoctoral Research Project Special Support Foundation

Publisher

Oxford University Press (OUP)

Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3